Sambol Anthony R, Hinrichs Steven H, Hogrefe Wayne R, Schweitzer Beth K
Nebraska Public Health Laboratory, University of Nebraska Medical Center, 986495 Nebraska Medical Center, Omaha, NE 68198-6495, USA.
Clin Vaccine Immunol. 2007 Jan;14(1):87-9. doi: 10.1128/CVI.00272-06. Epub 2006 Nov 22.
In 2003, the Nebraska Public Health Laboratory tested more than 10,371 serum and 516 cerebral spinal fluid specimens. Results showed that without performing the interfering factors screen for specimens in the low positive index value range of >1.1 to <or=3.5, a false positivity rate of 6.5% would have been realized.
2003年，内布拉斯加州公共卫生实验室检测了超过10371份血清样本和516份脑脊液样本。结果表明，如果不对指数值在>1.1至<或 = 3.5的低阳性范围内的样本进行干扰因素筛查，将会出现6.5%的假阳性率。
